His main research concerns Dementia, Alzheimer's disease, Internal medicine, Positron emission tomography and Pathology. His work deals with themes such as Biomarker, Psychiatry, Frontotemporal dementia and Statistical parametric mapping, which intersect with Alzheimer's disease. His Internal medicine research is multidisciplinary, relying on both Endocrinology, Magnetic resonance imaging and Neuroscience.
His Neuroscience research is multidisciplinary, incorporating elements of Psychopharmacology and Dopamine antagonist. His Positron emission tomography study integrates concerns from other disciplines, such as Volume of distribution, Pharmacokinetics and Cognitive impairment. His biological study spans a wide range of topics, including Reference tissue, Binding potential and Reference values.
The scientist’s investigation covers issues in Internal medicine, Positron emission tomography, Pathology, Disease and Dementia. The Internal medicine study combines topics in areas such as Endocrinology, Oncology and Cardiology. His study looks at the relationship between Positron emission tomography and topics such as In vivo, which overlap with Receptor.
Pathology is closely attributed to Magnetic resonance imaging in his work. His Disease course of study focuses on Neuroscience and Microglia. Bart N.M. van Berckel interconnects Alzheimer's disease, Neurology and Cohort in the investigation of issues within Dementia.
His primary areas of investigation include Internal medicine, Dementia, Disease, Cognitive decline and Neuroimaging. His Internal medicine research includes themes of Gastroenterology, Positron emission tomography, Endocrinology and Oncology. His work in Positron emission tomography tackles topics such as Pathology which are related to areas like Multiple sclerosis.
His work carried out in the field of Dementia brings together such families of science as Alzheimer's disease, Cognition, Pediatrics and Cohort. His Neuroimaging study improves the overall literature in Neuroscience. His Amyloid pet study, which is part of a larger body of work in Neuroscience, is frequently linked to Identical twins, bridging the gap between disciplines.
His primary areas of study are Dementia, Alzheimer's disease, Internal medicine, Cognitive decline and Neurology. His Dementia research is multidisciplinary, relying on both Positron emission tomography, Cognition and Cohort. Bart N.M. van Berckel works in the field of Positron emission tomography, focusing on Binding potential in particular.
His Alzheimer's disease research incorporates themes from Progressive supranuclear palsy, Amyotrophic lateral sclerosis, Hyperintensity and Amyloid. His work deals with themes such as Gastroenterology, Oncology and Episodic memory, which intersect with Internal medicine. His Neurology research includes elements of Pathology, Hippocampal formation, Cardiac imaging, Apolipoprotein E and Partial volume correction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study
Bart N. van Berckel;Matthijs G. Bossong;Ronald Boellaard;Reina Kloet.
Biological Psychiatry (2008)
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.
Matthijs G Bossong;Bart N M van Berckel;Bart N M van Berckel;Ronald Boellaard;Lineke Zuurman.
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment.
Maja A.A. Binnewijzend;Menno M. Schoonheim;Ernesto Sanz-Arigita;Alle Meije Wink.
Neurobiology of Aging (2012)
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy.
Optimizing patient care and research: the Amsterdam Dementia Cohort
Wiesje M van der Flier;Yolande A L Pijnenburg;Niels Prins;Afina W Lemstra.
Journal of Alzheimer's Disease (2014)
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
Stephanie J B Vos;Frans Verhey;Lutz Frölich;Johannes Kornhuber.
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
Daniëlle M. E. van Assema;Mark Lubberink;Mark Lubberink;Martin Bauer;Wiesje M. van der Flier.
Cerebral Blood Flow Measured with 3D Pseudocontinuous Arterial Spin-labeling MR Imaging in Alzheimer Disease and Mild Cognitive Impairment: A Marker for Disease Severity
Maja A A Binnewijzend;Joost P A Kuijer;Marije R Benedictus;Wiesje M van der Flier.
SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
David S.W. Djang;Marcel J.R. Janssen;Nicolaas Bohnen;Jan Booij.
The Journal of Nuclear Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: